SR ONE CAPITAL MANAGEMENT LLC 13D/13G Filings for Kala Pharmaceuticals, Inc. (KALA)

SR ONE CAPITAL MANAGEMENT LLC 13D and 13G filings for Kala Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-07-08
8:54 pm
Purchase
2024-06-2813DKala Pharmaceuticals, Inc.
KALA
SR ONE CAPITAL MANAGEMENT LLC445,643
9.990%
445,643increase
(New Position)
Filing